David Ortega

Director, Single-Cell Technology Facility. Associate Professor, School of Biomedical Engineering, University of Technology Sydney. Elaine Henry NBCF Fellow. Group Leader at Garvan Institute of Medical Research.

David Gallego Ortega, a leading expert in Single-Cell Technology, is the Director of this cutting-edge field at the University of Technology Sydney (UTS) along with being the Group Leader at the Garvan Institute of Medical Research, specializing in Breast Cancer and Single-Cell Genomics.

David's academic journey includes a PhD in Biochemistry from Universidad Autónoma de Madrid and a B.Sc in Biology with a Major in Genetics from Universidad Complutense de Madrid, illustrating his strong foundation in the biological sciences.

With an impressive array of roles, David has held positions such as Associate Professor at UTS, former Group Leader and Elaine Henry NBCF Fellow at the Garvan Institute, and Conjoint Senior Lecturer at UNSW, showcasing his depth of experience in academia and research.

David's professional history is rich with impactful roles, including being a Cancer Institute New South Wales Career Development Fellow and Senior Research Officer at the Garvan Institute, highlighting his contributions to the field of medical research, particularly in Breast Cancer studies.

Having served as a Conjoint Lecturer at UNSW and holding prestigious fellowships from the National Breast Cancer Foundation, Cure Cancer Australia Foundation, and various other research and academic positions, David's expertise and dedication to advancing medical research is evident.

Prior to his current roles, David has garnered experience as a Postdoctoral Researcher at TCD Pharma, a PhD student at the Spanish Council for Scientific Research, and has contributed significantly to research efforts at Hospital Fundación Jiménez Díaz, showcasing his global perspective and involvement in diverse research settings.